Kalbitor 10 mg/mL
Ecallantide · INJECTION, SOLUTION · Takeda Pharmaceuticals America, Inc.
Kalbitor is a injection, solution containing ecallantide at 10 mg/mL, taken subcutaneous. Manufactured by Takeda Pharmaceuticals America, Inc..
Key Facts
- Brand Name
- Kalbitor
- Generic Name
- Ecallantide
- NDC Code (Product)
47783-101- Manufacturer
- Takeda Pharmaceuticals America, Inc.
- Strength
- 10 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA125277
- Drug Class
- Plasma Kallikrein Inhibitor [EPC]
- Marketing Start
- 02/02/2010
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is Kalbitor used for?
Kalbitor contains Ecallantide. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is Kalbitor a controlled substance?
Kalbitor is not classified as a controlled substance by the DEA.
What is the generic name for Kalbitor?
The generic name for Kalbitor is Ecallantide. There are no other listed brand versions of Ecallantide.
What is the NDC code for Kalbitor 10 mg/mL?
The NDC (National Drug Code) for Kalbitor 10 mg/mL is 47783-101, listed by Takeda Pharmaceuticals America, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)